While SSRI antidepressants can help in offering relief from symptoms, in comparison, psilocybin or magic mushrooms might be ...
A new study compared psilocybin — the active compound in magic mushrooms, with a common antidepressant medication. During 6 ...
Cognitive Research Corporation (CRC), a leading CNS-focused clinical research organization, proudly announces the addition of ...
Participants in a recent study who took this psychedelic drug not only alleviated depression symptoms, they also got a boost ...
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic- ...
Analyst Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Cybin (CYBN – Research Report) and increased the price target ...
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...
Here’s a look at the best and worst states in each of the four data categories: mental health provider ratio, suicide rate ...
Teva Pharma announces long term efficacy and safety of deutetrabenazine in European patients with debilitating movement disorder tardive dyskinesia: Tel Aviv, Israel Tuesday, Sept ...
Fintel reports that on September 23, 2024, EF Hutton initiated coverage of Reviva Pharmaceuticals Holdings (NasdaqCM:RVPH) ...
NAC supplements scientifically termed as N-acetylcysteine supplements have gained considerable attention in recent years ...